Role of potassium-competitive acid blockers in eradication of Helicobacter pylori infection
Tae Ho Kim
Korean J Intern Med. 2023;38(4):451-453.   Published online 2023 Jun 30     DOI: https://doi.org/10.3904/kjim.2023.250
Citations to this article as recorded by Crossref logo
Tegoprazan: a novel, highly selective, and potent potassium-competitive acid blocker (P-CAB)
Wenlu Wang, Hafiza Sidra Yaseen, Xiaoji Li, Muhammad Zia Ahmad, Yaowu Chen, Guorong Li, Muhammad Naveed, Hafiz Muhammad Zubair, Jannat Bibi
European Journal of Clinical Pharmacology.2025;[Epub]     CrossRef